| Financial Year |
March 31 2023 |
| Monetary Funds |
272,655,126.84 |
| Held-for-trading Financial Assets |
21,183,000.00 |
| Notes Receivable |
149,796.00 |
| Accounts Receivable |
614,183,532.40 |
| Advances to Suppliers |
22,610,603.26 |
| Other Receivables |
95,535,514.34 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
295,441,885.11 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
428,949.46 |
| Total Current Assets |
1,322,188,407.41 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
32,440,327.23 |
| Investment Properties |
13,096,459.00 |
| Fixed Assetes |
129,987,535.28 |
| Under-construction Projects |
28,001,279.19 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
259,018,849.77 |
| R&D expenses |
45,512,834.32 |
| Goodwill |
481,535,662.58 |
| Long-Term Deferred and Prepaid Expenses |
2,377,455.93 |
| Deferred Income Tax Assets |
33,258,927.47 |
| Other Non-Current Assets |
219,403,994.52 |
| Sub-Total of Non-Current Assets |
1,269,902,147.07 |
| Total Assets |
2,592,090,554.48 |
| Short-Term Loans |
62,499,975.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
50,739,039.02 |
| Accounts Payable |
165,068,404.28 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
12,111,561.60 |
| Taxes Payable |
11,295,164.54 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
10,869,126.74 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
3,492,494.79 |
| Other Current Liabilities |
11,210,189.89 |
| Sub-Total of Current Liabilities |
402,527,721.47 |
| Long-term Loans |
13,845,908.98 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
3,983,564.11 |
| Sub-Total of Non-Current Liabilities |
23,564,155.18 |
| Total Liabilities |
426,091,876.65 |
| Paid-In Capital(Or Share Stock) |
481,092,495.00 |
| Capital Surplus |
601,032,530.11 |
| Surplus Reserve |
90,872,949.58 |
| LESS:Treasury Stock |
49,987,055.84 |
| Undistributed Profits |
882,963,757.99 |
| Minority Stockholder's Interest |
162,377,611.10 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,003,621,066.73 |
| Owner's Equity（Stockholder's Equity） |
2,165,998,677.83 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,592,090,554.48 |
